Drug Database
Back to search

Poland· PL-100132069

Acatar Acti-Tabs

A pseudoephedrine product containing pseudoephedrini hydrochloridum + triprolidini hydrochloridum, registered in Poland by US Pharmacia Sp. z o.o.. The same ATC class is registered in 6 of our 19 countries.

ATC R01BA02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAcatar Acti-TabsATCR01BA02REGISTER NO.PL-100132069PACKS LISTED5CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about pseudoephedrini hydrochloridum + triprolidini hydrochloridumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Pseudoephedrine is registered in 6 of 19 countries.

Countries holding a registration under ATC R01BA02 (pseudoephedrine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 4 of them publish a price we can compare per daily dose
Search pseudoephedrine products by name

Pseudoephedrine · ATC R01BA02

6 / 19 countries

  • Belgiumprice
  • Ireland
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Pseudoephedrini hydrochloridum + Triprolidini hydrochloridum
Manufacturer
US Pharmacia Sp. z o.o.
Country
Poland (PL)
ATC code
R01BA02
ATC class
Pseudoephedrine
Defined daily dose
0.24 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 5

  • gtin
    05909991114916
  • gtin
    05909991114923
  • gtin
    05909990422005
  • gtin
    05907377139010
  • gtin
    05907377139027

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

177 interactions on record for pseudoephedrine.

Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check pseudoephedrine against other medicinesHow interaction checks work

Pseudoephedrine · interactions on record

177 records

  • 16 severe
  • 153 moderate
  • 5 minor

Most severe, free to view

  • MethylergometrineG02AB01severe
  • ErgometrineG02AB03severe
  • LinezolidJ01XX08severe
  • ProcarbazineL01XB01severe

3 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pseudoephedrine in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pseudoephedrine products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Cyprus · Medofed
  • Germany · Rhinopront Kombi Tabletten
  • Estonia · Actifed
  • United Kingdom (Northern Ireland) · Multi-Action Actifed
  • Ireland · Actifed
  • Italy · Actifed
  • Lithuania · Actifed
  • Latvia · Actifed
  • Malta · Medofed
  • Portugal · Actifed, Dinaxil
  • Slovakia · Trifed

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/33bdc7fe-8075-4467-8af2-c1fb577c4fe7
GET /v1/drugs/33bdc7fe-8075-4467-8af2-c1fb577c4fe7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "60 mg + 2,5 mg",
  "packaging": "05909991114916 ¦ OTC ¦ 25800\n6 tabl.\n05909991114923 ¦ OTC ¦ Skasowane ¦ 25801\n12 tabl. (2 x 6)\n05909990422005 ¦ OTC ¦ 48425\n12 tabl.\n05907377139010 ¦ OTC ¦ 85269\n2 tabl.\n05907377139027 ¦ OTC ¦ 85270\n4 tabl.",
  "substance": "Pseudoephedrini hydrochloridum 60 mg + Tripirolidini hydrochloridum 2.5 mg",
  "common_name": "Pseudoephedrini hydrochloridum + Triprolidini hydrochloridum",
  "pl_product_id": "100132069",
  "pozwolenie_nr": "11149",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about pseudoephedrine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console